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Chronic drainage of the thoracic duct to the esophagus was developed in dogs, and its 
efficacy in immunomodulation was tested using kidney transplantation. Compared to 
9.7 days in the control, the mean animal survival was prolonged to 9.9 days, 17.8 
days, and 18.5 days when TDD was applied preoperatively for 3 weeks, 6 weeks, and 
9 weeks, respectively. Prolongation was significant after 6 weeks. Patency of the 
fistula was 93.5, 80.4, and 76.1% at respective weeks. Number of peripheral T-lym-
phocytes determined by a new monoclonal antibody diminished after 3 weeks. All ani-
mals were in normal health, requiring no special care for fluid, electrolyte, or protein 
replacement. 
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Thoracic duct drainage (TDD) has had an important role in the history of immunosup-
pression, which began with the demonstration that rejection is an immunologic phenome-
non [1]. Strategies to weaken immune defenses for therapeutic purposes with irradiation 
[2] and steroids [3] culminated with the introduction of cytotoxic drugs of the 6-mercap-
topurine class [4-6]. Gowans' classical studies of thoracic duct drainage in rats in 1959 
[7] focused attention on the lymphocyte as a specific target for selective immunosuppres-
sion of the immune system. Attempts to reduce the lymphocyte mass with excision of 
lymphoid organs (spleen and thymus), antilymphocyte sera (ALS) or globulins (ALG), 
and total lymphoid irradiation (TLI) can be traced directly back to Gowans' work, which 
showed that both cellular and humoral immunity were profoundly depressed in the rat 
within 5 days of TDD [8]. Woodruff and Anderson [9] demonstrated an additive or syn-
ergistic effect ofTDD and ALG. 
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Attempts to apply TDD for clinical renal transplantation by Franksson [10] and oth-
ers [11-17] were disappointing. Much later, it was shown in patients with autoimmune 
diseases [18] and in transplant recipients [19-21] that immunosuppression was not 
demonstrable until after 3 to 4 weeks of TDD instead of the 5 days in rats. Studies in 
large animal were hampered, as they were in humans, by the difficulty of maintaining 
long-term external TDD. Techniques in dogs for internal drainage of thoracic duct lymph 
into the esophagus also were unreliable. Canine studies were further limited by the inabil-
ity to accurately monitor lymphocyte subpopulations. 
We have reexamined TDD in dogs, using a modification of an old technique that al-
lows the reliable internal drainage of thoracic duct lymph into the esophagus for more 
than 9 weeks. Immunosuppression was tested with renal allotransplantation. In addition, 
we developed a new monoclonal antibody called IYF-l, which recognizes enriched ca-
nine T-Iymphocytes and allows changes to be followed in the lymphocytes of the thoracic 
duct lymph and peripheral blood. 
Materials and Methods 
Surgical Procedure 
TDD. Female beagle dogs weighing 8.1-13.4 kg (Hazelton LRE, Kalamazoo, MI, USA) 
were anesthetized with intravenous sodium thiopental, nitrogen oxide, and halothane. To 
permit the easily identification of thoracic duct, the otherwise fasted dogs were given 100 
rnL of milk 2 h before the operation. A segment of vein into which the thoracic duct emptied 
was isolated after ligating the external jugular, subclavian, and inominate veins. The valves 
in this segment were disrupted by fine scissors to allow unimpeded flow of the lymph. The 
lymph was collected for 30 min. The external jugular vein segment was anastomosed to an 
ellipse of the cervical esophagus with interrupted 7-0 monofilament polybutester 
(Davis+Geck, Manati, PR) sutures, leaving the esophageal muscle layers open (Figure I). 
Esophagus 
~ .. ' ~ . .... . -~KD 
" . 
'. 
-Esophageal mucosa -~frD 
t.. ,,', 
~: :;K~ 
-.. :., 
.. ~l 
.. -:: :Oi 
:JIo • ~ 
:'; !. .. ~ 
,., ~Kr 
left eHtema' jugular lJeln 
14 gauge catheter 
thoracic duct 
Figure 1. Isolated left external jugular vein was anastomosed to esophageal mucosa. A 14-gauge 
catheter on which multiple side holes were made was inserted through the brachial vein to the 
esophageal cavity. Its external end was placed on the dorsal side of the neck and was protected by a 
jacket. The catheter was flushed with 1000 units of heparin in 10 mL of saline solution several 
times a day_ 
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Multiple side holes were made in a 14-gauge catheter (vyGON, East Rutherford, NJ, 
USA), which was inserted via a side branch of the external jugular vein segment through 
the anastomosis into the esophagus. The external part of the catheter was tunneled subcu-
taneously to the back of the neck and out through the skin. A protective jacket (Alice King 
Chatham Medical Arts, Los Angeles, CA, USA) was placed on the dog and the end of the 
catheter was seated in its pocket. The catheter was flushed several times a day with 1000 
units of heparin in 10 mL of saline solution. The patency of the anastomosis to the esopha-
gus was checked by weekly esophagoscopy performed under sodium thiopental anesthe-
sia, using an injection of diluted methylene blue through the catheter to facilitate location 
of the aperture. Dogs with failed TDD were eliminated from further studies. 
Kidney Transplantation. Dogs were divided into 4 groups for kidney transplantation: 
A (n = 6): control group, not pretreated 
B (n = 6): kidney transplant after 3 weeks TDD 
C (n = 6): kidney transplant after 6 weeks TDD 
D (n = 6): kidney transplant after 9 weeks TDD 
In addition, 1 dog was subject to renal xenotransplantation from a pig donor, using the 
same operative procedures. 
Anesthesia for kidney transplantation was the same as for the TDD. The jacket was 
taken off and the TDD catheter was removed. Kidney donors were female mongrel dogs 
weighing 10.4-15.4 kg. The allograft was placed into the right iliac fossa, vascularized 
from the iliac artery and vein, and drained with ureteroneocystostomy. Bilateral recipient 
nephrectomy was performed and 10 mg of furosemide was given intravenously. Cefaman-
dol (0.5 glday) was given 1M for 10 days. No N infusions, diuretics, or immunosuppres-
sive agents were given postoperatively. Ad libitum diet was started the next morning. The 
animals were sacrificed when the serum creatinine increased to more than 10 mgldL, or if 
the dogs developed disabling uremic manifestations such as vomiting and more than 20% 
of body weight loss. The animals were weighed once a week. Laboratory studies on days 
1, 2, 3, 5, and 7, and twice a week thereafter included total serum protein, albumin, and 
serum creatinine. Lymphocytes were prepared on Ficoll-Hypaque gradient (Pharmacia 
LKB Biochemistry, Piscataway, NJ, USA) once a week and stored at-70°C until the analysis. 
Immunologic Studies 
Monoclonal Antibody. Balb/c mice were purchased from Harlan Sprague Dawley (Indi-
anapolis, IN, USA) and immunized with the thymocytes of an adult female beagle dog 
that weighed 9.4 kg. The mice were immunized IP 4 times at 7-day intervals with 107 
thymocytes, which were prepared on Ficoll-Hypaque gradient. Four days after the final 
inoculation, 108 of the immunized mouse spleen cells were fused with 4.6 X 107 P-3 
mouse myeloma cells by polyethyleneglycol 1500 by the method of Lemke et al. [22]. 
After cell fusion, the cells were suspended in 200 mL of RPMI 1640 medium with 10% 
heat-inactivated fetal calf serum, and hypoxanthine-aminopterine-thymidine (GIBCO 
Laboratories, Grand Island, NY, USA). The mixture was then seeded into the cells in 
the presence of feeder cells obtained from Balb/c mouse spleen. After 24 h, the mixture 
was separated to 24-well culture plates. After cultivation for 14 days, the culture 
medium was replaced by a medium containing hypoxanthine-thymidine (GIBCO), and 
the supernatant was screened by indirect immunofluorescence for antibody activity 
against a variety of dog cells. The positive hybrids were cloned by limiting dilution. 
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The monoclonal antibody designated IYF-l, which reacted with T -cells was used for 
further studies. 
Cell Fractionation. Macrophages were separated by differential adherence [24] from 
lymphocytes prepared on Ficoll-Hypaque gradient. After the separation of macrophages, 
T-cells and B-cells were separated by Nylon-wool column [23]. Red cells and platelets 
were separated by centrifugation [25]. 
FACS Analysis. Cells under study were treated with a saturating amount of 0.1 mL of 
IYF-I for 30 min at 4°C and washed twice with phosphate-buffer solution (PBS). Those 
cells were then incubated with fluorescein-conjugated goat anti-mouse IgM antibody with 
50% beagle dog serum-PBS for 30 min at 4°C and washed twice with PBS. The cells 
were fixed in 2% paraformaldehyde-PBS and samples were run on Becton-Dickinson 
FACScan (Mountain View, CA, USA). 
Statistics 
The unpaired t test and generalized Wilcoxon test were applied for statistical analysis of 
group means. A probability of <.05 was considered significant. 
Results 
Clinical Observations 
All dogs were in normal health during TDD with no evidence of dehydration, loss of 
body weight, or decrease of serum total protein and albumin. Lymph flow and count from 
the isolated vein segment for the initial 30 min were 346.0 ± 14.4 (SE) mL and 444.9 ± 
346.0/mm3• The patency of the esophageal fistula was 93.5% in 3 weeks, 80.4% in 6 
weeks, and 76.1 % in 9 weeks. After kidney transplantation and the removal of the TDD 
catheter, the dogs remained well until the onset of rejection. 
Graft and Dog Survival 
Graft survival is summarized in Table 1. One dog each in groups Band C were sacrificed 
at postoperative days 7 and 15 with low serum creatinine levels because of intussuscep-
tion. The survival of the group B animal (mean 12.0 days) was not significantly different 
from that in group A (9.7 days). Survival of animals in group C (17.8 days) and group D 
(18.5 days) was significantly prolonged. 
The pig kidney transplanted to the canine recipient after 56 days TDD was hypera-
cutely rejected in 8 min. 
Immunologic Studies 
Peripheral Lymphocytes During TDD. The percentage of lymphocytes and the lym-
phocyte counts fell in the first week and remained depressed thereafter. The counts 
drifted down as long as the TDD was in place (Figure 2) from 1656.6 ± 85.4/mm3 
to 956.7 ± 83.6/mm3 in 9 weeks. The reduction of lymphocyte count was 
significantly different from that of 0 weeks except at weeks 2 and 4 (p < .01 by un-
paired t test). 
TDD in Canine Renal Transplantation 363 
Table 1 
Prolongation of renal allograft survival in dogs 
Duration of 
Group TDD (weeks) n Survival datesa Mean 
A 0 6 8, 9, 9, 9, 10, 13 9.7 
B 3 6 7,c 9,11,11,17,17 12.0 NS 
C 6 6 15,c 15, 17, 18, 18,24 17.8 0.004 
D 9 6 9, 17, 18, 22, 22, 23 18.5 0.02 
a Dogs were sacrificed when the grafts were rejected, that is, at more than 10 mgldL of serum 
creatinine, or when symptoms of severe uremic syndrome appeared, like appetite loss, vomiting, 
and mroe than 20% of body weight loss. 
bBy generalized Wilcoxon method. 
e Dogs were sacrificed from intussusception with low serum creatinine level. 
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Figure 2. Changes in peripheral lymphocyte during TDD (mean ± SE). Lymphocyte counts of the 
2nd and 4th weeks were not significantly different from that at 0 weeks, while others were p < .01 
by unpaired t test. 
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Monoclonal Antibody and Peripheral T-cells During TDD. The immunoglobulin of sub-
class of the monoclonal antibody IYF-l was IgM K light chain. All of the peripheral en-
riched T -cells were stained by indirect immunofluorescence, whereas B-cells, red blood 
cells, and platelet were not stained (Table 2). The percentage of T -cells did not show a 
consistent change. However, the count of T-cells went to a significantly lower level (p = 
.01) at all time points except week 2 (Figure 3). 
Discussion 
Internal TDD has been described many times since 1963 [27-32] with unsatisfactory 
chronic drainage, except for Kawai et al. [27] who were able to maintain patent fistulas 
for 6 weeks in 30% of their dogs. Our technique (Figure 1) differed from theirs mainly in 
the position of the catheter, which was led through the esophageal anastomosis (instead 
of retrograde into the duct), in the frequent flushing of the catheter, and in the placement 
of multiple side holes in the catheter. 
The dogs were healthy after internal TDD. They did not require the fluid and pro-
tein replacement or electrolyte correction that are needed with external TDD in animals 
or humans [33]. The temporal development of demonstrable immunosuppression was 
more like that in humans than the 5-day required rats. Kidney graft survival was not 
significantly altered by 3 weeks of TDD but was doubled after 6 and 9 weeks. As in hu-
mans [19-21], this timing of therapeutic effect was out of phase with the T-Iymphocyte 
count, which was depressed almost immediately after TDD and remained low thereafter. 
In Gowans' original rat experiments [7] and with long-term external TDD in humans 
[18-21], humoral and cellular immunity were both depressed. This duality was controver-
sial at the time of the human trials because at that time a pure cell-mediated effect was ex-
pected or reported by some investigators. The obtundation of humoral immunity in these 
earlier human studies was consistent with the observation that TDD appeared to favorably 
alter the prognosis of patients who had renal transplants against widely reacting cytotoxic 
antibodies [9]. 
Table 2 
Reactivity of IYF-l in normal beagle dog 
peripheral blood cells 
Peripheral Cell SO 
T-cells 
B-cells 
Macrophages 
Red cells 
Platelets 
Reaction With IYF-l (%) 
100 
o 
40 
o 
o 
aBy indirect immunofluorescence. 
Note. Macrophages were separated by differ-
ential adherence from lymphocytes prepared on 
Ficoll-Hypaque gradient. After the separation of 
macrophages, T -cells and B-cells were separated by 
Nylon-wool column. Red cells and platelets were 
separated by centrifugation. 
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Figure 3. Changes in peripheral T-cells during TDD (mean ± SE). Population ofT-cells was mea-
sured by indirect fluorescent using monoclonal antibody, IYF-1. T-cell count of 2nd week was not 
significantly different from that at 0 weeks, while others were p < .01 by unpaired t test. 
The present experiments were not designed to test if T -lymphocyte depletion can af-
fect humoral reactivity, except for one experiment of pig to dog renal heterotransplanta-
tion. The heterograft was hyperacutely rejected in spite of 56 days pretreatment with 
TDD. It is possible that a secondary loss of B-lymphocyte and NK cell function will re-
quire much longer pedods of T-cell depletion. 
Examination of such questions is increasingly possible because of the monoclonal anti-
bodies made possible by the somatic cell hybridization techniques of Kohler and Milstein 
[34]. However, although dogs are frequently used in transplant studies, very few monoclonal 
antibodies are available for characterization of dog lymphocytes [35-40]. Our monoclonal 
antibody, IYF-I, was raised against beagle dog thymocytes and had an reactivity to 100% of 
peripheral enriched T -cells. There is the possibility that IYF-I will have therapeutic effect in 
dogs similar to that of OKT-3 in humans. Further studies to test this hypothesis are planned. 
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